Skip to main content
. Author manuscript; available in PMC: 2010 Dec 29.
Published in final edited form as: Neuroscience. 2009 Sep 25;164(4):1653–1664. doi: 10.1016/j.neuroscience.2009.09.049

Figure 4.

Figure 4

Immunoblots of p-JNK (A). PCNs were treated with or without ALC at the dose of 1000 mg/dl for the indicated duration (h), n=3. Immunoblot analyses for p-JNK are shown in B. Values are shown as mean ± SEM. * p<0.05